RECURSION PHARMACEUTICALS, INC. (RXRX) Operating cash flow 2019–2025
RECURSION PHARMACEUTICALS, INC. (RXRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$371.8MFY2025 · since FY2019: -$57.0M → -$371.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$371.8M | -3.5% |
| FY2024 | -$359.2M | -24.8% |
| FY2023 | -$287.8M | -244.5% |
| FY2022 | -$83.5M | +47.3% |
| FY2021 | -$158.6M | -249.4% |
| FY2020 | -$45.4M | +20.4% |
| FY2019 | -$57.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice